Comparison of two twice-daily insulin regimens: Ultralente/soluble and soluble/isophane


The relative efficacy of two twice-daily insulin regimens using highly purified insulins, once daily Ultratard with twice daily Actrapid (ultralente/soluble) and twice daily Actrapid with twice daily Retard (soluble/isophane), has been studied in 12 diabetics in a cross-over study. Control was optimised as an out-patient, and assessed by in-patient 24 hour… (More)
DOI: 10.1007/BF00252686


1 Figure or Table

Slides referencing similar topics